| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.095 | 0.1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |